Related Experiment Videos

[The evaluation of cell proliferation in gliomas]

K Alkiza1, B Adán, J M Garibi

  • 1Departamento de Neurociencias, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Bilbao. alkiza@euskalnet.net onplasav@lg.ehu.es

Revista De Neurologia
|March 24, 2000
PubMed
Abstract

Insights

Assessing cell proliferation in gliomas using methods like PCNA, Ki-67, BrdU, and DNA ploidy helps predict tumor behavior. High proliferation markers indicate more malignant gliomas, aiding in prognosis.

Area of Science:

  • Neuro-oncology
  • Cell cycle regulation
  • Cancer biology

Context:

  • Tissue homeostasis relies on controlled cell growth, differentiation, and death.
  • Altered cell cycle proteins can lead to uncontrolled proliferation and cancer.
  • Cell proliferation assessment is crucial for understanding glioma behavior in neuro-oncology.

Purpose:

  • To analyze various methods for studying cell proliferation in gliomas.
  • To evaluate the utility of immunostaining (PCNA, Ki-67), DNA flow cytometry, and BrdU incorporation.
  • To correlate these proliferation markers with glioma prognosis.

Summary:

  • This study examines techniques including PCNA and Ki-67 immunostaining, DNA content and ploidy analysis via flow cytometry, and in vitro bromodeoxyuridine (BrdU) incorporation.
  • Flow cytometry for DNA analysis reveals a link between ploidy and glioma prognosis.
  • PCNA assessment offers objective data on glioma proliferative activity, with Ki-67 and BrdU also proving valuable.

Impact:

  • Highly malignant gliomas exhibit frequent aneuploidies and elevated PCNA, Ki-67, and BrdU labeling indices.
  • These proliferation assessment methods serve as valuable prognostic markers.
  • They complement existing criteria for glioma diagnosis and management.

Related Concept Videos